HISTORICAL INTRODUCTION* 



At a special meeting of the Committee on Standards 

 and Deteriorations, American Drug Manufacturers' 

 Association, held at the Waldorf-Astoria, New York, 

 March 30, 1917, it was decided that an historical in- 

 vestigation of the drugs and preparations official in the 

 Pharmacopeia of the United States was an important 

 and much-needed work that could be properly under- 

 taken and contributed to the world under the auspices 

 of the Association. It was deemed essential that the 

 publication should be accompanied by bibliographical 

 data sufficient to enable one engaged in special re- 

 search to obtain first-hand references to publications 

 embracing the history of the subjects included. An 

 appropriation adequate to cover the necessary expense 

 was made and approved. 



The Committee to undertake this work, as announced 

 by Mr. Charles J. Lynn, President of the Association, 

 consisted of the following: 



Dr. A. R. L. Dohme, Chairman, 

 Dr. J. M. Francis, 

 Dr. John Uri Lloyd. 



Since the Lloyd Library, Cincinnati, Ohio, carried 

 the documents and publications essential for this re- 

 search, Dr. Lloyd was requested to formulate a work- 

 ing plan in accordance with which the work might be 



* The author comprehends that the members of the American Drug Manufacturers' 

 Association are fully informed of the facts this Introduction includes. However, as the 

 publication is not to be restricted to the members of this Association, others may either 

 now or at a period more or less remote need the data here presented, which in this sense 

 may be considered as an historical part of the publication. J. U. L. 



